J&J’s potential neurovascular exit: implications for market dynamics
The Financial Times recently reported that Johnson & Johnson (J&J) is considering the sale of Cerenovus, its neurovascular division. The post J&J’s potential neurovascular exit: implications for market dynamics appeared first on Medical Device Network.
The Financial Times recently reported that Johnson & Johnson (J&J) is considering the sale of Cerenovus, its neurovascular division.
The post J&J’s potential neurovascular exit: implications for market dynamics appeared first on Medical Device Network.
